BACR Precision medicine and cancer models : Developing strategies to enhance clinical response 2017

BACR Precision medicine and cancer models : Developing strategies to enhance clinical response is organized by The British Association for Cancer Research (BACR) and would be held on Nov 21, 2017 at The Royal Society of Medicine, London, England, United Kingdom. The target audience for this medical event for oncologists.

The use of preclinical and clinical information to inform patient selection for novel cancer therapies is key, with the development and use of models to interrogate target dependencies based on molecular pathology being well-established. Recent studies also suggest that it may be valuable to integrate additional information into patient selection hypotheses, including considerations of tumor metabolism, the type and extent of immunological infiltrate in a tumour, or the acquisition of a mesenchymal phenotype. This one-day conference involves leading investigators working at the translational interface in oncology to better define disease subtypes and guide precision medicine decisions.

Topics include :

• Use of models and clinical material to inform subtyping of colorectal cancer
• Classifying tumours based on immunogenic subtype
• Biomarker strategies to improve the personalisation of breast cancer treatment
• Experimental strategies to reveal therapeutic targets in liver cancer
• Modelling the microenvironment in ERa-positive breast cancer
• Modelling pancreatic adenocarcinoma and potential therapeutic approaches

Additional details will be posted as soon as they are available.